New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
15
1143

Diabetes Drugs

A overview of the main groups of drugs used in diabetes with some side effects  
David Fish
almost 5 years ago
Preview
7
213

Complications of High Blood Pressure or Hypertension - adidarwinian

Complications of High Blood Pressure or Hypertension can be a multitude of deadly diseases including Heart Attack, Stroke, Kidney Failure, Vision Loss, etc.  
adidarwinian.com
about 5 years ago
12
2
94

Diabetes

Diabetes factsheet from WHO providing key facts and information on types of diabetes, symptoms, common consequences, economic impact, diagnosis and treatment, WHO response. Updated November 2014.  
who.int
over 4 years ago
Preview
1
22

Primary Care and Diabetes: What's New in 2015

Endocrinology experts guide primary care docs on managing patients with diabetes.  
medpagetoday.com
over 4 years ago
3e6dca6f7ba1cbedb92d3b80157979453dc000288656160631124576
9
325

Hypoglycemic drugs for diabetes treatment - Ahmados

One A3 note summarize the hypoglycemic drugs ( mechanism of action , uses , side effects ) and how to approach a patient with diabetes.  
Ahmados Academy
about 4 years ago
Preview
1
7

Type 2 diabetes prevention: population and community-level interventions | Guidance and guidelines | NICE

NICE's recommendations aim to help prevent type 2 diabetes among populations and communities of adults who are at high risk. Risk factors include being overweight or obese and whether or not someone is physically active. In addition to these individual risk factors, certain ethnic communities and people from lower socioeconomic groups are particularly at risk.  
nice.org.uk
about 4 years ago
Preview
1
10

Type 2 diabetes: prevention in people at high risk | Guidance and guidelines | NICE

This guidance is not advocating a national screening programme for type 2 diabetes, rather the recommendations remind practitioners that age is no barrier to being at high risk of, or developing, type 2 diabetes.  
nice.org.uk
about 4 years ago
Preview
1
8

Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) | key-points-from-the-evidence | Advice | NICE

High‑strength insulin products such as insulin glargine 300 units/ml (Toujeo) have been developed for people with large daily insulin requirements to reduce the number and volume of injections. In 1 randomised controlled trial (RCT) in 549 people with type 1 diabetes, Toujeo had similar efficacy to insulin glargine 100 units/ml (Lantus) in terms of HbA1c reduction, but the basal insulin dose used was higher with Toujeo than with Lantus. There was no benefit of Toujeo over Lantus in terms of reduced hypoglycaemic events. The safety profile of Toujeo is largely similar to that of Lantus. Toujeo is not bioequivalent to Lantus and they are not interchangeable without dose adjustment.  
nice.org.uk
about 4 years ago
5
1
8

Type 2 diabetes mellitus | Advice | NICE

This document summarises the evidence-base on type 2 diabetes mellitus. It is a key therapeutic topic which has been identified to support Medicines Optimisation. It is not formal NICE guidance.  
nice.org.uk
about 4 years ago
Preview
1
10

Type 2 diabetes: alogliptin | Relevance-to-NICE-guidance-programmes | Advice | NICE

The NICE clinical guideline on type 2 diabetes, published in 2009, is currently being updated. The final scope for this update specifies that the marketing authorisation for alogliptin is not anticipated in time for inclusion within the guideline, so alogliptin will not be included in this update.  
nice.org.uk
about 4 years ago
Preview
1
7

Type 2 diabetes: dulaglutide | Key-points-from-the-evidence | Advice | NICE

For reducing HbA1c levels in people with type 2 diabetes, dulaglutide once weekly, when added to metformin, was statistically superior to exenatide twice daily (both in combination with pioglitazone), statistically superior to sitagliptin and statistically non‑inferior to liraglutide 1.8 mg daily. As with the other glucagon‑like peptide‑1 (GLP‑1) receptor agonists there are limited data from randomised controlled trials (RCTs) on the effect of dulaglutide on patient‑oriented outcomes, such as rates of macrovascular or microvascular events, or on long‑term safety.  
nice.org.uk
about 4 years ago
Preview
0
6

Diabetes Mellitus - CRASH! Medical Review Series

(Disclaimer: The medical information contained herein is intended for physician medical licensing exam review purposes only, and are not intended for diagnos...  
youtube.com
almost 4 years ago
Preview
0
6

Outpatient Management of Diabetes Mellitus - CRASH! Medical Review Series

(Disclaimer: The medical information contained herein is intended for physician medical licensing exam review purposes only, and are not intended for diagnos...  
youtube.com
almost 4 years ago
941160a7acd183072e7c61820af432a7966cc52d7131987142796123
1
13

Drugs use in Diabetes

An overview of the drugs used in Diabetes.  
Kristian Dye
almost 4 years ago
Bb3673240ca68c042644f885c78b0896fac195a7596494272762652
1
17

Guide to Insulins

An overview of the insulins in use, with their uses, action profiles, preparations and devices.  
Kristian Dye
almost 4 years ago
Ee456679fca933bf1952ed9f35ab20b0e3cb517d8490926292945744
1
14

Atheroma

Atheromatous vascular disease  
Mrs Malaika Smith
over 3 years ago
Preview
1
32

Lifestyle management of type 2 diabetes #351

Type 2 diabetes is a complex systems disease, caused by interactions between lifestyle and genes. It is an illusion to believe that it can be cured by medication. Lifestyle change should always be at the heart of treatment.  
soundcloud.com
about 1 year ago